Business ModelSHC has a durable business model with exposure to commercial pharmaceutical and medical devices, which are less volatile in an economic downturn due to the necessary nature of the products.
Regulatory RequirementsNelson volumes are benefiting from new regulatory requirements across various end-markets, including bioprocessing and medtech.
Volume TrendsManagement was positive on volume trends across Steri and Nelson, with new customer inquiries due to NESHAP regulations stressing competing facilities.